TARO PHARMS FDA Approval ANDA 211722

ANDA 211722

TARO PHARMS

FDA Drug Application

Application #211722

Application Sponsors

ANDA 211722TARO PHARMS

Marketing Status

Prescription001

Application Products

001SPRAY;TOPICALEQ 0.05% BASE/SPRAY0BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATE

FDA Submissions

UNKNOWN; ORIG1AP2020-06-17STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

TARO PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211722
            [companyName] => TARO PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"BETAMETHASONE DIPROPIONATE","activeIngredients":"BETAMETHASONE DIPROPIONATE","strength":"EQ 0.05% BASE\/SPRAY","dosageForm":"SPRAY;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/17\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-17
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.